What Does Pregnenolone Do in Your Body and Brain?

Pregnenolone is the starting material your body uses to manufacture virtually every steroid hormone you have, from cortisol and testosterone to estrogen and progesterone. But it is far more than a raw ingredient waiting to be converted into something else. In the brain, pregnenolone and its sulfated form act directly on nerve-cell receptors, influence memory processes, dampen inflammation, and even shape sleep architecture. The range of roles is broad enough that researchers sometimes call it the “grandmother” of steroid hormones, a label that undersells how much it does on its own.

How Pregnenolone Gets Made

The process starts with cholesterol. In your adrenal glands, ovaries, or testes, an enzyme complex centered on a protein called CYP11A1 clips the side chain off cholesterol and converts it into pregnenolone.¹ This reaction happens inside mitochondria, the energy-producing compartments of cells. Once pregnenolone is formed, it can be shuttled into different biochemical pathways depending on which tissue made it and what that tissue needs. In adrenal cells, it feeds into cortisol production. In the gonads, it heads toward sex hormones. In the brain, interestingly, glial cells appear to synthesize pregnenolone through a related but distinct mitochondrial enzyme rather than CYP11A1 itself, suggesting the brain has its own partly independent supply.²

This local production matters because pregnenolone is lipophilic, meaning it dissolves readily in fats and crosses the blood-brain barrier with ease.³ So the brain gets pregnenolone two ways: from the bloodstream and from its own internal manufacturing. The fact that the brain bothers to make its own hints at how important local concentrations are for neural function.

The Steroid Hormone Starting Point

Every major class of steroid hormone traces back to pregnenolone. The pathways branch almost immediately. One branch leads through progesterone toward cortisol and aldosterone (the hormones that manage stress responses, blood pressure, and electrolyte balance). Another branch leads through DHEA toward testosterone and estrogen. A third branch produces the neurosteroids allopregnanolone and pregnenolone sulfate, which act directly inside the nervous system. These downstream hormones are then further processed by the liver and peripheral tissues, creating an intricate web of metabolites that show up in blood and urine.⁴

Because pregnenolone sits at the very top of this cascade, anything that changes how much of it your body produces can ripple across multiple hormone systems at once. This is one reason supplementing with pregnenolone is trickier than it sounds: you’re not just raising one hormone, you’re potentially shifting an entire network.

What Pregnenolone Does at Nerve-Cell Receptors

Pregnenolone sulfate, the sulfated version that forms readily in the brain, has a split personality at two of the most important receptor types in your nervous system. At NMDA receptors, which are excitatory and central to learning, it boosts activity. In rat hippocampal tissue, pregnenolone sulfate enhanced the response to NMDA-receptor activation and strengthened long-term potentiation, the cellular process widely considered the basis of memory formation.⁵ Research has identified a high-potency signaling pathway through which pregnenolone sulfate drives more NMDA receptors to the cell surface, amplifying the signal further.⁶

At GABA-A receptors, which are inhibitory and normally calm neural activity, pregnenolone sulfate does roughly the opposite: it reduces receptor responses. It does this not by blocking the channel directly but through a slower process that shortens the bursts of receptor activity triggered by GABA.⁷ The net effect is a subtle shift toward excitation and alertness. This dual action, turning up the excitatory dial and turning down the inhibitory one, helps explain why pregnenolone sulfate consistently shows up in memory and cognition research.

Memory and Cognitive Effects

The connection between pregnenolone sulfate and memory has been explored most thoroughly in aging rodents. In a landmark study, aged rats with lower pregnenolone sulfate levels in the hippocampus (the brain’s primary memory-processing region) performed worse on spatial memory tasks. The relationship was specific to the hippocampus: levels in the amygdala, prefrontal cortex, and other brain areas did not predict memory performance. When researchers injected pregnenolone sulfate directly into the hippocampus of cognitively impaired aged rats, the memory deficit temporarily reversed.⁸

Dose matters, though, and more is not simply better. When researchers tested pregnenolone sulfate on spatial working memory in rats and mice using a Y-maze, the dose-response curve was an inverted U: moderate doses improved memory, but higher doses did not continue to help.⁹ That pattern is common with neuroactive compounds and is worth keeping in mind for anyone tempted to megadose a supplement.

Microtubule Assembly and Cellular Architecture

One of the more surprising findings about pregnenolone is that it interacts directly with the structural scaffolding inside brain cells. Pregnenolone binds to a protein called MAP2, which helps organize microtubules, the internal “beams” that give neurons their shape and serve as highways for transporting materials along axons and dendrites. In lab experiments, pregnenolone produced a large, dose-dependent increase in both the speed and extent of microtubule assembly driven by MAP2. Progesterone, by contrast, did nothing on its own and actually counteracted pregnenolone’s stimulatory effect.¹⁰

This matters because disrupted microtubule dynamics show up in several neurological and neurodevelopmental conditions. Researchers have noted that pregnenolone and a related compound can positively affect MAP2 binding and the behavior of other microtubule-associated proteins that are deregulated in conditions like depression and CDKL5 deficiency disorder, a rare genetic epilepsy.¹¹ The microtubule angle is still relatively new in clinical terms, but it gives pregnenolone a mode of action that has nothing to do with its role as a hormone precursor.

Protecting Neurons from Damage

In cell culture, pregnenolone protected hippocampal cells against two common causes of neuronal death: excess glutamate (the same excitatory neurotransmitter whose receptors pregnenolone sulfate enhances, though the protective mechanism here is different) and amyloid beta protein, the sticky peptide that accumulates in Alzheimer’s disease. The optimal protective concentration was quite low, and the effect appeared to involve preventing a stress-related receptor from moving into the cell nucleus.¹²

In live animals, the story gets more nuanced. When rats were given a toxin that specifically damages hippocampal neurons, pregnenolone showed dose-dependent protective effects. But blocking the enzyme aromatase, which converts pregnenolone into estradiol, erased the protection entirely. This suggests that at least some of pregnenolone’s neuroprotective power in vivo comes not from pregnenolone itself but from the estradiol it generates locally in the brain.¹³ It’s a useful reminder that in a living system, pregnenolone is constantly being converted into other things, and those downstream products often share credit for the effects.

Inflammation and the Immune System

Beyond the nervous system, pregnenolone plays a role in dialing down inflammation. In macrophages and microglial cells (the brain’s resident immune cells), pregnenolone promotes the breakdown of an adaptor protein called TIRAP that is crucial for signaling through toll-like receptors TLR2 and TLR4. These receptors are among the first responders of innate immunity, and when they fire excessively, they drive chronic inflammation. Pregnenolone and its metabolites suppressed the release of the pro-inflammatory signaling molecules TNF-alpha and interleukin-6 through this pathway.¹⁴

This anti-inflammatory action is separate from anything cortisol does. Cortisol is a potent anti-inflammatory hormone made downstream from pregnenolone, but pregnenolone appears to have its own direct dampening effect on immune signaling before it ever gets converted into cortisol. Whether this is clinically meaningful in humans at physiological concentrations is still under study, but the mechanism is well-documented in cell and animal models.

Effects on Sleep

Pregnenolone influences sleep in a way that distinguishes it from most sedative compounds. In a human study, pregnenolone increased the time spent in slow-wave sleep, the deepest and most restorative stage, and reduced EEG sigma power (the frequency band associated with lighter non-REM sleep stages).¹⁵ In rats, pregnenolone enhanced delta activity during non-REM sleep throughout the recording period, consistent with acting as a functional inverse agonist at the GABA-A-benzodiazepine receptor site.¹⁶

This is the opposite of what benzodiazepines do: drugs like midazolam increase lighter sleep stages and suppress slow-wave sleep. Pregnenolone pushes sleep in the other direction, toward deeper stages. For people who sleep lightly or wake frequently, this profile sounds appealing, though controlled trials large enough to guide clinical use in insomnia are still missing.

A Built-In Brake on Cannabis Overstimulation

One of the more striking discoveries about pregnenolone came from research on the endocannabinoid system. When THC, the main psychoactive compound in cannabis, activates the CB1 receptor in the brain, it triggers a large increase in pregnenolone synthesis. That extra pregnenolone then acts as a signaling-specific inhibitor of CB1, dampening several of THC’s effects. In other words, the brain uses pregnenolone as a built-in negative feedback loop to protect itself from cannabinoid overstimulation.¹⁷

This feedback loop was previously unknown and opened a line of research into whether pregnenolone-based compounds could be developed to treat cannabis use disorders. The mechanism is notable because pregnenolone does not simply block CB1 the way an antagonist drug would, which tends to cause anxiety and other unpleasant side effects. Instead, it selectively inhibits certain downstream signaling pathways while leaving others intact.

Clinical Trials in Psychiatric Conditions

Human trials of pregnenolone have focused primarily on schizophrenia and bipolar depression, two conditions where standard treatments leave a lot of room for improvement.

In schizophrenia, negative symptoms (emotional flatness, lack of motivation, social withdrawal) are notoriously hard to treat with existing antipsychotics. A proof-of-concept trial found that patients receiving adjunctive pregnenolone showed significantly greater improvement in negative symptom scores compared with placebo.¹⁸ A larger follow-up trial in patients with recent-onset schizophrenia confirmed the finding, reporting a moderate effect size for negative symptom reduction over eight weeks. The benefit was particularly clear in patients not already taking mood stabilizers.¹⁹ Elevations in pregnenolone and its metabolite allopregnanolone after treatment were correlated with cognitive improvements, suggesting the benefit may extend beyond negative symptoms.²⁰

In bipolar depression, a randomized trial found that pregnenolone produced higher remission rates than placebo on one of the two depression scales used (about 61% versus 37%). The treatment appeared safe and well tolerated.²¹ A smaller trial in patients with co-occurring depression and a history of substance use found trends toward improvement in both depressive and manic symptoms, though statistical significance was reached only in a secondary analysis of people who completed the full trial.²²

These results are encouraging but still preliminary. The trials have been small, and the field needs larger, multi-site studies before pregnenolone could be recommended as a standard add-on therapy. The consistent signal across multiple trials and conditions, though, has kept research interest alive.

Pregnenolone and the Stress Response

The relationship between pregnenolone and the body’s stress machinery is not straightforward. In people with alcohol use disorder, pregnenolone supplementation at doses of 300 and 500 milligrams restored a more normal hormonal stress response. Specifically, these participants showed a significantly higher cortisol-to-ACTH ratio during stress, whereas the placebo group had a blunted response, meaning their adrenal glands were not reacting to stress signals the way healthy glands should.²³

Interestingly, in monkeys, the regulation of circulating pregnenolone does not follow the simple path you might expect. Injecting ACTH, the pituitary hormone that tells the adrenal glands to ramp up cortisol production, did not raise pregnenolone levels and actually lowered them after prior treatment with a cortisol-suppressing drug. By contrast, a drug that blocks opioid receptors did raise pregnenolone levels.²⁴ This suggests that pregnenolone production in the body is regulated by more than just the standard stress-hormone axis and may be influenced by opioid signaling pathways as well.

The Supplement Question

Pregnenolone is sold over the counter in many countries as a dietary supplement, typically in doses of 10 to 100 milligrams. Because it sits at the top of the steroid cascade, taking it orally can potentially influence levels of cortisol, DHEA, testosterone, estrogen, progesterone, and allopregnanolone, though how much of it survives first-pass liver metabolism and where it actually ends up varies from person to person.

A broader concern about “adrenal support” supplements applies here. An analysis of commercially available supplements marketed for adrenal health found that many contained measurable amounts of bioactive steroid hormones and thyroid hormones, which could interfere with hormonal testing and lead to misdiagnosis of hormone-related conditions.²⁵ Someone taking pregnenolone before a blood test for cortisol or sex hormones could get results that look abnormal simply because of the supplement. If you are having hormonal workups done, your provider needs to know about any steroid-related supplements you are taking.

The clinical trials in schizophrenia and bipolar depression generally used doses much higher than what is found in typical retail supplements, sometimes in the hundreds of milligrams, under medical supervision. Extrapolating from those trials to casual self-supplementation is unreliable, and the inverted-U dose-response pattern seen in animal memory studies is another reason to be cautious about the “more is better” approach.

An Evolutionarily Ancient Molecule

The brain’s ability to synthesize its own pregnenolone from cholesterol is not unique to humans. Research across vertebrates, including birds, amphibians, and other mammals, has confirmed that brain cells in all these groups express steroidogenic enzymes and produce neurosteroids locally.²⁶ The conservation of this machinery over hundreds of millions of years of evolution is a strong indication that local neurosteroid production does something important enough that losing it would be a serious disadvantage. In birds and amphibians, a pregnenolone derivative called 7-alpha-hydroxypregnenolone has been identified as a regulator of locomotor activity, a role that has no obvious parallel in the human literature yet but underscores how versatile pregnenolone-derived molecules can be across different species.